Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Shoichiro Kosha"'
Autor:
Shoichiro Kosha, Yukie Yonehara, Ichiro Iwamoto, Yoshiatsu Sagara, Tsutomu Douchi, Yoshiaki Rai
Publikováno v:
Journal of Obstetrics and Gynaecology Research. 33:696-699
Aim: To investigate aromatase inhibitor-induced bone mineral loss and its prevention by bisphosphonate administration in postmenopausal breast cancer patients. Methods: Subjects were 17 postmenopausal breast cancer patients (mean age, 63.3 ± 9.9 yea
Autor:
Shoichiro Kosha, Tsutomu Douchi, Mitsuhiro Nakae, Nobuyuki Yoshimitsu, Yukihiro Nagata, Toshimichi Oki, Hirofumi Uto
Publikováno v:
Maturitas. 46:133-138
Objective: The present study investigated the sequence of certain phenomena with a few years after menopause: bone mineral loss, decrease in lean body mass, increase in body fat mass, or the shift toward upper body fat distribution. Methods: Subjects
Publikováno v:
Gynecologic and Obstetric Investigation. 53:144-148
The effects of vitamin K2 on bone mineral density (BMD) and bone metabolic markers of ovariectomized rats, and those on mRNA expression of osteocalcin and IL-6 on a rat osteoblastic cell line, were investigated. BMD and bone metabolic markers were ex
Autor:
Tsutomu Douchi, Shoichiro Kosha, Toshinori Fujino, Masato Murakami, Yukihiro Nagata, Ichiro Iwamoto
Publikováno v:
Acta Obstetricia et Gynecologica Scandinavica. 79:1060-1064
Background. Leptin might affect bone metabolism. This study was performed to investigate the relationship of leptin to bone metabolism in detail in premenopausal and postmenopausal healthy women.Methods. The relationships between serum leptin level a
Autor:
Yukihiro Nagata, Ichiro Iwamoto, Masato Murakami, Shoichiro Kosha, Toshinori Fujino, Shin-ichi Noguchi, Tsutomu Douchi
Publikováno v:
Maturitas. 31:161-164
Objectives : To investigate the effect of vitamin K 2 treatment for a year on spinal bone mineral density (BMD) in postmenopausal women, comparing with vitamin D 3 hormone replacement therapy and to determine the factors which affect the efficacy of
Autor:
Yasuaki Sagara, Yoshito Matsuyama, Yoshiaki Sagara, Shinichi Baba, Shugo Tamada, Tsutomu Douchi, Yoshiatsu Sagara, Fumiko Dokiya, Mitsutake Ando, Yoshiaki Rai, Yasuyo Ohi, Shoichiro Kosha
Publikováno v:
Breast cancer (Tokyo, Japan). 17(3)
Although anastrozole (ANA), an aromatase inhibitor (AI), has been widely used for breast cancer patients; adverse events during ANA therapy in Japanese patients have not been reported. The study included 656 postmenopausal breast cancer patients rece
Autor:
Yukie Yonehara, Tsutomu Douchi, Yoshihisa Umekita, Ichiro Iwamoto, Yoshiatsu Sagara, Shoichiro Kosha, Yoshiaki Rai
Publikováno v:
Maturitas. 57(3)
Aim The aim was to investigate bone mineral density (BMD) in breast cancer patients with positive estrogen receptor (ER) tumor status. Methods The participants were 110 postmenopausal breast cancer patients with positive estrogen receptor (ER+) tumor
Publikováno v:
Maturitas. 42(3)
Objectives: To investigate the differences in leptin production between pre- and postmenopausal women. Methods: Subjects were 75 pre- and 75 postmenopausal women. Age, height, weight, and body mass index (BMI, wt/ht 2 ) were recorded. Serum leptin le
Publikováno v:
Gynecologic and obstetric investigation. 53(3)
The effects of vitamin K(2) on bone mineral density (BMD) and bone metabolic markers of ovariectomized rats, and those on mRNA expression of osteocalcin and IL-6 on a rat osteoblastic cell line, were investigated. BMD and bone metabolic markers were
Autor:
Yukihiro Nagata, Isamu Matsumoto, Shin-ichi Noguchi, Toshimichi Oki, Shoichiro Kosha, Nobuko Kojima, Tsutomu Douchi
Publikováno v:
Journal of obstetrics and gynaecology (Tokyo, Japan). 21(5)
Objective: To explore the effects of pregnancy and postpartal lactation on bone mineral density (BMD). Methods: In this study, the BMD of 22 pregnant women in a longitudinal study, and of 75 pregnant and 111 puerperant women in a cross-sectional stud